J&J sells off its feminine side; Manhattan Research's study on the sales rep "tablet dance"; Cepheid rolls out a consumer TB campaign; and healthcare sector job losses top out in July.
Merck came late to the iPad party, but the company has made up the distance by releasing a global template for details using the device.
Pharmas are spending far less on reprints and far more on digital promotion to physicians and other healthcare professionals, according to a healthcare media buying specialist.
HPV vaccine price cut; Merck files new allergy med with FDA; GSK pursues online transparency; Walgreens ready for greater nurse autonomy; Epocrates ranks high among docs with tablets.
Takeda's 1,800 field reps are getting a new tool, Google changes its AdWords program.
From tech shifts to talent, and from emerging markets to engaging with social media, agency execs offer their predictions for what the New Year will bring.
HBA honors Cardinal Health, BMS adds another drug to the trash heap, Spyglass says nurses don't really like iPads and Cochrane finds texting is a good way to help smokers become quitters.
Studies show that printed pieces still hold sway in the industry.
Statistics show medical professionals are migrating toward iPads. Now, one medical journal publisher says, advertisers have followed.
WebMD the Magazine is now part of the iPad app world.
- Sunovion hires former BI exec as VP of marketing
- Five things for pharma marketers to know: Thursday, October 20, 2016
- Five things for pharma marketers to know: Monday, October 24, 2016
- Five things for pharma marketers to know: Tuesday, October 25, 2016
- Five things for pharma marketers to know: Wednesday, October 26, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- Novartis considers new sales model for experimental cancer therapy